And Then Came Monkeypox: What to Know About the Recent Outbreak
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Dermatology
Psoriasis Linked With Risk for Severe and Rare Infections
The risk for severe and rare infections in patients with psoriasis—mild or severe—is assessed.
Contact Skin Radiation Therapy in Treating BCC and SCC During COVID Outbreak
The feasibility and safety of contact skin radiation therapy (CSRT) for the treatment of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) during the COVID-19 pandemic is evaluated.
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
For patients with psoriasis, vitiligo, atopic dermatitis (AD), and chronic urticaria (CU), COVID-19 severity does not differ, but treatment of COVID-19 may affect the course of skin disease.
COVID-19 Pandemic’s Effect on Patients With Psoriatic Disease
The effect of the COVID-29 pandemic on the hospital admissions and treatment adherences of patients with psoriasis are examined.
Apremilast Not Tied to Increased SARS-CoV-2 Infection Risk in Patients With Psoriasis
Researchers sought to determine the percentage of patients with psoriasis who contracted COVID-19 while receiving apremilast.
Safety, Efficacy of Levamisole in Individuals With Loiasis Infection
Researchers conducted a study to assess the safety and efficacy of levamisole in individuals with loiasis parasitic infection.
Does Quinine Potentiate Antimicrobial Blue Light Therapy in Patients With Cutaneous Mold Infection?
Investigators conducted a study to determine the effects of quinine hydrochloride in combination with antimicrobial blue light therapy in patients with cutaneous mold infection.
Combination Antiretroviral Therapy and CD4/CD8 Ratio on the Risk for Kaposi Sarcoma, Non-Hodgkin Lymphoma in Patients With HIV Infection
Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.
First Generic Version of Clindagel Gets FDA Approval
Clindamycin phosphate EQ 1% gel is indicated for topical application in the treatment of acne vulgaris.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...